What is the share price of Clinitech Laboratory Ltd (CTLLAB) today?
The share price of CTLLAB as on 1st September 2026 is ₹35.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Clinitech Laboratory Ltd (CTLLAB) share?
The past returns of Clinitech Laboratory Ltd (CTLLAB) share are- Past 1 week: 0.29%
- Past 1 month: -8.83%
- Past 3 months: -12.03%
- Past 6 months: -0.28%
- Past 1 year: -31.67%
- Past 3 years: N/A%
- Past 5 years: -70.93%
What are the peers or stocks similar to Clinitech Laboratory Ltd (CTLLAB)?
The peers or stocks similar to Clinitech Laboratory Ltd (CTLLAB) include:What is the market cap of Clinitech Laboratory Ltd (CTLLAB) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Clinitech Laboratory Ltd (CTLLAB) is ₹8.44 Cr as of 1st September 2026.What is the 52 week high and low of Clinitech Laboratory Ltd (CTLLAB) share?
The 52-week high of Clinitech Laboratory Ltd (CTLLAB) is ₹47.15 and the 52-week low is ₹28.55.What is the PE and PB ratio of Clinitech Laboratory Ltd (CTLLAB) stock?
The P/E (price-to-earnings) ratio of Clinitech Laboratory Ltd (CTLLAB) is 20.11. The P/B (price-to-book) ratio is 0.91.Which sector does Clinitech Laboratory Ltd (CTLLAB) belong to?
Clinitech Laboratory Ltd (CTLLAB) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Clinitech Laboratory Ltd (CTLLAB) shares?
You can directly buy Clinitech Laboratory Ltd (CTLLAB) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Clinitech Laboratory Ltd
CTLLAB Share Price
BSE₹35.104.10% (-1.50)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CTLLAB Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CTLLAB Performance & Key Metrics
CTLLAB Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.91 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.20 | 5.92 | 0.48% |
CTLLAB Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CTLLAB Company Profile
Clinitech Laboratory Ltd provides diagnostic and healthcare tests through centers in Thane and Navi Mumbai, offering over 150 types of tests including biochemistry and microbiology.
PE Ratio
41.38
41.38
1Y Return
15.47%
15.47%
Buy Reco %
77.78
77.78
POLYMED
PE Ratio
54.31
54.31
1Y Return
16.43%
16.43%
Buy Reco %
80.00
80.00
PE Ratio
89.11
89.11
1Y Return
23.67%
23.67%
TARSONS
PE Ratio
113.81
113.81
1Y Return
2.33%
2.33%
Buy Reco %
100.00
100.00
LAXMIDENTL
PE Ratio
37.58
37.58
1Y Return
42.93%
42.93%
Buy Reco %
100.00
100.00
CTLLAB Forecast
CTLLAB Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CTLLAB
CTLLAB
Income
Balance Sheet
Cash Flow
Quarterly Normal View
CTLLAB Income Statement
CTLLAB Income Statement
Quarterly Normal View
Hmm, looks like data is unavailable here. Please come back after some timeCTLLAB Company Updates
CTLLAB Stock Peers
CTLLAB Past Performance & Peer Comparison
CTLLAB Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Clinitech Laboratory Ltd | 20.11 | 0.91 | — |
| Inventurus Knowledge Solutions Ltd | 41.38 | 10.66 | — |
| Poly Medicure Limited | 54.31 | 5.56 | 0.20% |
| Molbio Diagnostics Limited | 89.11 | 11.34 | — |
CTLLAB Stock Price Comparison
Compare CTLLAB with any stock or ETFCompare CTLLAB with any stock or ETF
CTLLAB
CTLLAB Holdings
CTLLAB Shareholdings
CTLLAB Promoter Holdings Trend
CTLLAB Promoter Holdings Trend
CTLLAB Institutional Holdings Trend
CTLLAB Institutional Holdings Trend
No institutional holdings trend are available
CTLLAB Shareholding Pattern
CTLLAB Shareholding Pattern
CTLLAB Shareholding History
CTLLAB Shareholding History
Foreign Institutions
smallcases containing CTLLAB stock
smallcases containing CTLLAB stock
Looks like this stock is not in any smallcase yet.
CTLLAB Events
CTLLAB Events
CTLLAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CTLLAB has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CTLLAB Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CTLLAB has not given any dividends in last 5 years
CTLLAB Dividends
CTLLAB Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCTLLAB Stock News & Opinions
CTLLAB Stock News & Opinions
Articles & Videos
Corporate
Corporate
Clinitech Laboratory closes share transfer books for its 16th Annual General MeetingClinitech Laboratory Limited informed the BSE Limited, National Securities Depository Limited, and Central Depository Services (India) Limited that the register of members and share transfer books will be closed from Friday, September 18, 2025, to Thursday, September 24, 2026, for the company’s 16th Annual General Meeting scheduled to be held on Thursday, September 24, 2026, at 11:30 A.M. (IST).
4 weeks agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory Limited to convene a board meeting on August 17, 2026Clinitech Laboratory Limited will hold a board meeting on August 17, 2026, via video conference to consider the appointment of a retiring director, approve the company’s FY 2025-26 board’s report, finalize the notice for the 16th Annual General Meeting, and appoint Mr. Deep Shukla, Practising Company Secretary, as the scrutinizer for the voting process, according to a regulatory filing.
1 month agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory announces board meeting dateClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 28 May 2026.
3 months agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory to conduct board meetingClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 22 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory to conduct board meetingClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory to conduct AGMClinitech Laboratory announced that the 15th Annual General Meeting(AGM) of the company will be held on 23 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory to announce Quarterly ResultClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 19 August 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory to conduct board meetingClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 6 June 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory announces board meeting dateClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Clinitech Laboratory to hold board meetingClinitech Laboratory will hold a meeting of the Board of Directors of the Company on 25 March 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 1.79%
Pledged promoter holdings is insignificant